挪威1型自身免疫性多内分泌综合征长期随访研究
该研究基于挪威全国注册数据,对71例APS-1患者(49例经典型、22例非经典型)进行1996-2025年纵向随访,描述其临床特征、自身抗体与AIRE基因型关联,并与999例非APS-1患者比较原发性肾上腺功能不全(PAI)诊断年龄。经典型以慢性黏膜皮肤念珠菌病、釉质发育不良和PAI最常见,非经典型以白癜风、甲状腺功能减退和PAI最常见;经典型可见广泛促炎细胞因子特征及可溶性IFN-α/β受体升高。
要点
- 20岁前诊断PAI的患者应考虑APS-1,并推荐AIRE测序确诊。
- 经典型APS-1常见慢性黏膜皮肤念珠菌病、釉质发育不良和PAI。
- IFN-ω自身抗体、促炎细胞因子谱及可溶性IFN受体升高支持干扰素通路失调。
核心结论
- APS-1应在20岁前诊断PAI的患者中考虑,并推荐AIRE测序用于诊断确认。
- IFN-ω自身抗体、促炎细胞因子谱及可溶性IFN受体水平升高支持干扰素反应失调在APS-1发病中的作用。
研究设计与样本
- 研究分析挪威器官特异性自身免疫病注册中心71例APS-1患者(49例经典型、22例非经典型)1996-2025年纵向临床与实验室数据。
- 比较有与无APS-1患者(n=999)的原发性肾上腺功能不全诊断年龄。
主要发现
- 经典型APS-1最常见的临床表现为慢性黏膜皮肤念珠菌病、釉质发育不良和PAI。
- 非经典型APS-1最常见的临床表现为白癜风、甲状腺功能减退和PAI。
- 经典型APS-1中观察到广泛的促炎细胞因子特征,以及可溶性干扰素-α/β受体水平升高。
临床怎么用
- 对20岁前诊断原发性肾上腺功能不全的患者,应考虑APS-1并进行AIRE测序以确诊。
- IFN-ω自身抗体、促炎细胞因子谱及可溶性IFN受体水平可辅助支持APS-1的诊断与发病机制评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Autoimmune polyendocrine syndrome type 1 (APS-1) is a rare yet severe multiorgan autoimmune disease caused by mutations in the autoimmune regulator (AIRE) gene. Classical APS-1 arises from biallelic recessive AIRE mutations, whereas dominant negative mutations cause a milder, nonclassical phenotype with variable clinical presentation. Due to its rarity, long-term, population-based data are limited, underscoring the need for extended follow-up to guide lifelong care and research. OBJECTIVE: To characterize the clinical profiles of APS-1 and explore associations between disease manifestations, autoantibody profiles, and AIRE mutations over an extended follow-up (1996-2025). PATIENTS: All known Norwegian patients with APS-1. METHODS: We analyzed longitudinal clinical and laboratory data of 71 APS-1 patients (49 classical, 22 nonclassical) from the Norwegian Registry of Organ-specific Autoimmune Diseases. Data included clinical progression, autoantibody and cytokine profiles, and AIRE genotypes. Additionally, we compared age at diagnosis of primary adrenal insufficiency (PAI) in patients with and without (n = 999) APS-1. RESULTS: In classical APS-1, the most frequent clinical manifestations were chronic mucocutaneous candidiasis, enamel hypoplasia, and PAI, while for nonclassical APS-1 vitiligo, hypothyroidism, and PAI were most common. A broad proinflammatory cytokine signature was observed in classical APS-1, along with increased levels of the soluble form of the interferon (IFN)-α/β receptor. CONCLUSION: APS-1 should be considered in patients diagnosed with PAI before age 20, and AIRE sequencing is recommended for diagnostic confirmation. The presence of IFN-ω autoantibodies, a proinflammatory cytokine profile, and increased soluble IFN receptor levels further support the role of dysregulated interferon responses in APS-1 pathogenesis.
引用
- Kucuka I, Wolff ASB, Breivik L, et al. Long-term follow-up of autoimmune polyendocrine syndrome type 1 in Norway. J Clin Endocrinol Metab. 2026. PMID: 41678364. doi:10.1210/clinem/dgag060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。